The realities of administering advanced therapies in the clinic is our industry's next big challenge. So, what is the clinician's perspective on what's needed to effectively and safely bring advanced therapies to patients?
Professor Marc Turner, professor of Cellular Therapy and Medical Director at the Scottish National Blood Transfusion Service and Dr Maria Pia Cicalese, IRCCS San Raffaele gave us their insight and answered the following questions in this video...
- What is the scale of the clinical need for ATMPs?
- Are specific centres of excellence the answer to patient access?
- How can ATMP manufacturers simplify product handling in the clinic?
- What role can clinicians play in securing funding for advanced therapies?